We are live on ! Find out more
JJ

Johnson & Johnson Portfolio holdings

AUM $799M
1-Year Est. Return 253.51%
This Fund
S&P 500
This Quarter Est. Return
+17.7%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$344M
AUM Growth
+$3.89M
Cap. Flow
+$3.93M
Cap. Flow %
1.14%
Top 10 Hldgs %
92.24%
Holding
23
New
1
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
MGTX icon
MeiraGTx Holdings
MGTX
+$25.7M
2
CLSD
Clearside Biomedical
CLSD
+$204K
3
NNOX icon
Nano X Imaging
NNOX
+$42.1K

Top Sells

Rank Stock Value
1
PRCT icon
Procept Biorobotics
PRCT
+$21.7M
2
PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
+$283K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEGN icon
1
Legend Biotech
LEGN
$3.93B
$81.3M 23.66%
1,629,173
– –
CVRX icon
2
CVRx
CVRX
$78.3M
$64.1M 18.66%
3,495,575
– –
MGTX icon
3
MeiraGTx Holdings
MGTX
$1.17B
$43.3M 12.6%
6,641,064
+3,742,514
+129% +$25.7M
FATE icon
4
Fate Therapeutics
FATE
$294M
$34.1M 9.92%
3,379,064
– –
PTGX icon
5
Protagonist Therapeutics
PTGX
$9.8B
$26.7M 7.77%
2,449,183
– –
XNCR icon
6
Xencor
XNCR
$1.71B
$19.5M 5.67%
748,062
– –
PRCT icon
7
Procept Biorobotics
PRCT
$1.26B
$14.9M 4.33%
357,939
-505,969
-59% -$21.7M
FUSN
8
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$11.6M 3.36%
3,670,516
– –
HLTH
9
DELISTED
Cue Health Inc. Common Stock
HLTH
$11.5M 3.34%
5,548,864
– –
ARWR icon
10
Arrowhead Research
ARWR
$12.1B
$10M 2.92%
247,598
– –
PNT
11
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$7.29M 2.12%
1,000,000
– –
VOR icon
12
Vor Biopharma
VOR
$1.38B
$7.15M 2.08%
53,733
– –
ACET icon
13
Adicet Bio
ACET
$77.3M
$6.52M 1.9%
45,559
– –
ALDX icon
14
Aldeyra Therapeutics
ALDX
$86.9M
$2.75M 0.8%
394,834
– –
NNOX icon
15
Nano X Imaging
NNOX
$73.2M
$1.45M 0.42%
196,228
+3,799
+2% +$42.1K
SLGC
16
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$705K 0.21%
281,052
– –
PHGE icon
17
BiomX
PHGE
$1.67M
$398K 0.12%
11,228
– –
CLSD
18
DELISTED
Clearside Biomedical
CLSD
$190K 0.06%
+11,309
New +$204K
TCON
19
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$125K 0.04%
4,200
– –
SENS icon
20
Senseonics Holdings Inc
SENS
$409M
$56K 0.02%
2,731
– –
GYRE icon
21
Gyre Therapeutics
GYRE
$693M
$35K 0.01%
8,927
– –
CALC icon
22
CalciMedica
CALC
$20.2M
$25K 0.01%
3,539
– –
PHAS
23
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
– –
-1,607,044
Closed -$283K

Similar funds

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
UM
Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
AI
Aperture Investors New York $791M AUM 54.66% 1-Year Est. Return

Johnson & Johnson's Q4 2022 Portfolio in Review

As of Q4 2022, Johnson & Johnson held 23 positions worth $344M, up 1.1% from $340M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Johnson & Johnson's Q4 2022 filing shows 1 new, 2 increased, 1 reduced and 1 closed positions. Its largest new stake was Clearside Biomedical: 11,309 shares worth $190K. The largest sale was Procept Biorobotics, an estimated $21.7M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Johnson & Johnson's largest Q4 2022 buy was Clearside Biomedical: 11,309 shares worth $190K.
  • Johnson & Johnson added most to MeiraGTx Holdings in Q4 2022, an estimated $25.7M increase.
  • Johnson & Johnson's biggest Q4 2022 reduction was Procept Biorobotics, cutting an estimated $21.7M.
  • Johnson & Johnson fully exited PhaseBio Pharmaceuticals, Inc. Common Stock in Q4 2022, selling an estimated $283K.
  • Johnson & Johnson's ten largest holdings make up 92% of its $344M portfolio in Q4 2022.
  • Johnson & Johnson opened 1 new position and closed 1 in Q4 2022.
  • Johnson & Johnson's portfolio value rose 1.1% quarter-over-quarter to $344M.

Based on Johnson & Johnson's 13F filing for Q4 2022, filed 9 Feb 2023.